EMEA Radiopharmaceutical Market by Manufacturers, Regions, Type and Application, Forecast to 2022

September 2017 | 120 pages | ID: EC90DA2BD90EN
GlobalInfoResearch

Abstracts

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Scope of the Report:

This report focuses on the Radiopharmaceutical in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Bayer
• Triad Isotopes
• Lantheus
• GE Healthcare
• Mallinckrodt
• Eli Lilly
• Bracco Imaging
• SIEMENS
• Navidea
• Nordion
• IBA Group
• Jubilant Pharma

Market Segment by Regions, regional analysis covers

• Europe (Germany, France, UK, Russia, Italy and Turkey)
• Middle East (Saudi Arabia, Israel, UAE and Iran)
• Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers

• Diagnostic Radioisotopes
• Therapeutic Radioisotopes

Market Segment by Applications, can be divided into

• Oncology
• Cardiology
• Other

There are 13 Chapters to deeply display the EMEA Radiopharmaceutical market.

Chapter 1, to describe Radiopharmaceutical Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Radiopharmaceutical, with sales, revenue, and price of Radiopharmaceutical, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Radiopharmaceutical, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Radiopharmaceutical research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Radiopharmaceutical Introduction
1.2 Market Analysis by Type
  1.2.1 Diagnostic Radioisotopes
  1.2.2 Therapeutic Radioisotopes
1.3 Market Analysis by Applications
  1.3.1 Oncology
  1.3.2 Cardiology
  1.3.3 Other
1.4 Market Analysis by Regions
  1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
    1.4.1.1 Germany Market States and Outlook (2012-2022)
    1.4.1.2 France Market States and Outlook (2012-2022)
    1.4.1.3 UK Market States and Outlook (2012-2022)
    1.4.1.4 Italy Market States and Outlook (2012-2022)
    1.4.1.5 Russia Market States and Outlook (2012-2022)
    1.4.1.6 Turkey Market States and Outlook (2012-2022)
  1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
    1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.2.2 UAE Market States and Outlook (2012-2022)
    1.4.2.3 Israel Market States and Outlook (2012-2022)
    1.4.2.4 Iran Market States and Outlook (2012-2022)
  1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
    1.4.3.1 South Africa Market States and Outlook (2012-2022)
    1.4.3.2 Nigeria Market States and Outlook (2012-2022)
    1.4.3.3 Egypt Market States and Outlook (2012-2022)
    1.4.3.4 Algeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Bayer
  2.1.1 Business Overview
  2.1.2 Radiopharmaceutical Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Triad Isotopes
  2.2.1 Business Overview
  2.2.2 Radiopharmaceutical Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Lantheus
  2.3.1 Business Overview
  2.3.2 Radiopharmaceutical Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 GE Healthcare
  2.4.1 Business Overview
  2.4.2 Radiopharmaceutical Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mallinckrodt
  2.5.1 Business Overview
  2.5.2 Radiopharmaceutical Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly
  2.6.1 Business Overview
  2.6.2 Radiopharmaceutical Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bracco Imaging
  2.7.1 Business Overview
  2.7.2 Radiopharmaceutical Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 SIEMENS
  2.8.1 Business Overview
  2.8.2 Radiopharmaceutical Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Navidea
  2.9.1 Business Overview
  2.9.2 Radiopharmaceutical Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Nordion
  2.10.1 Business Overview
  2.10.2 Radiopharmaceutical Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 IBA Group
  2.11.1 Business Overview
  2.11.2 Radiopharmaceutical Type and Applications
    2.11.2.1 Type
    2.11.2.2 Type
  2.11.3 IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Jubilant Pharma
  2.12.1 Business Overview
  2.12.2 Radiopharmaceutical Type and Applications
    2.12.2.1 Type
    2.12.2.2 Type
  2.12.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 EMEA RADIOPHARMACEUTICAL MARKET COMPETITION, BY MANUFACTURER

3.1 EMEA Radiopharmaceutical Sales and Market Share by Manufacturer
3.2 EMEA Radiopharmaceutical Revenue and Market Share by Manufacturer
3.3 EMEA Radiopharmaceutical Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Radiopharmaceutical Manufacturer Market Share
  3.4.2 Top 5 Radiopharmaceutical Manufacturer Market Share
3.5 Market Competition Trend

4 EMEA RADIOPHARMACEUTICAL MARKET ANALYSIS BY REGIONS

4.1 EMEA Radiopharmaceutical Sales, Revenue and Market Share by Regions
  4.1.1 EMEA Radiopharmaceutical Sales by Regions (2012-2017)
  4.1.2 EMEA Radiopharmaceutical Revenue by Regions (2012-2017)
4.2 Europe Radiopharmaceutical Sales and Growth (2012-2017)
4.3 Middle East Radiopharmaceutical Sales and Growth (2012-2017)
4.4 Africa Radiopharmaceutical Sales and Growth (2012-2017)

5 EUROPE RADIOPHARMACEUTICAL BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 Europe Radiopharmaceutical Sales, Revenue and Market Share by Countries
  5.1.1 Europe Radiopharmaceutical Sales by Countries (2012-2017)
  5.1.2 Europe Radiopharmaceutical Revenue by Countries (2012-2017)
  5.1.3 Germany Radiopharmaceutical Sales and Growth (2012-2017)
  5.1.4 France Radiopharmaceutical Sales and Growth (2012-2017)
  5.1.5 UK Radiopharmaceutical Sales and Growth (2012-2017)
  5.1.6 Russia Radiopharmaceutical Sales and Growth (2012-2017)
  5.1.7 Italy Radiopharmaceutical Sales and Growth (2012-2017)
  5.1.8 Turkey Radiopharmaceutical Sales and Growth (2012-2017)
5.2 Europe Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
  5.2.1 Europe Radiopharmaceutical Sales by Manufacturers (2016-2017)
  5.2.2 Europe Radiopharmaceutical Revenue by Manufacturers (2016-2017)
5.3 Europe Radiopharmaceutical Sales by Type (2012-2017)
5.4 Europe Radiopharmaceutical Sales by Application (2012-2017)

6 MIDDLE EAST RADIOPHARMACEUTICAL BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Middle East Radiopharmaceutical Sales, Revenue and Market Share by Countries
  6.1.1 Middle East Radiopharmaceutical Sales by Countries (2012-2017)
  6.1.2 Middle East Radiopharmaceutical Revenue by Countries (2012-2017)
  6.1.3 Saudi Arabia Radiopharmaceutical Sales and Growth (2012-2017)
  6.1.4 Israel Radiopharmaceutical Sales and Growth (2012-2017)
  6.1.5 UAE Radiopharmaceutical Sales and Growth (2012-2017)
  6.1.6 Iran Radiopharmaceutical Sales and Growth (2012-2017)
6.2 Middle East Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
  6.2.1 Middle East Radiopharmaceutical Sales by Manufacturers (2016-2017)
  6.2.2 Middle East Radiopharmaceutical Revenue by Manufacturers (2016-2017)
6.3 Middle East Radiopharmaceutical Sales by Type (2012-2017)
6.4 Middle East Radiopharmaceutical Sales by Application (2012-2017)

7 AFRICA RADIOPHARMACEUTICAL BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Africa Radiopharmaceutical Sales, Revenue and Market Share by Countries
  7.1.1 Africa Radiopharmaceutical Sales by Countries (2012-2017)
  7.1.2 Africa Radiopharmaceutical Revenue by Countries (2012-2017)
  7.1.3 South Africa Radiopharmaceutical Sales and Growth (2012-2017)
  7.1.4 Nigeria Radiopharmaceutical Sales and Growth (2012-2017)
  7.1.5 Egypt Radiopharmaceutical Sales and Growth (2012-2017)
  7.1.6 Algeria Radiopharmaceutical Sales and Growth (2012-2017)
7.2 Middle East Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
  7.2.1 Middle East Radiopharmaceutical Sales by Manufacturers (2016-2017)
  7.2.2 Middle East Radiopharmaceutical Revenue by Manufacturers (2016-2017)
7.3 Middle East Radiopharmaceutical Sales by Type (2012-2017)
7.4 Middle East Radiopharmaceutical Sales by Application (2012-2017)

8 EMEA RADIOPHARMACEUTICAL MARKET SEGMENT BY TYPE

8.1 EMEA Radiopharmaceutical Sales, Revenue and Market Share by Type (2012-2017)
  8.1.1 EMEA Radiopharmaceutical Sales and Market Share by Type (2012-2017)
  8.1.2 EMEA Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
8.2 Diagnostic Radioisotopes Sales Growth and Price
  10.2.1 EMEA Diagnostic Radioisotopes Sales Growth (2012-2017)
  10.2.2 EMEA Diagnostic Radioisotopes Price (2012-2017)
8.3 Therapeutic Radioisotopes Sales Growth and Price
  10.3.1 EMEA Therapeutic Radioisotopes Sales Growth (2012-2017)
  10.3.2 EMEA Therapeutic Radioisotopes Price (2012-2017)

9 EMEA RADIOPHARMACEUTICAL MARKET SEGMENT BY APPLICATION

9.1 EMEA Radiopharmaceutical Sales Market Share by Application (2012-2017)
9.2 Oncology Sales Growth (2012-2017)
9.3 Cardiology Sales Growth (2012-2017)
9.4 Other Sales Growth (2012-2017)

10 EMEA RADIOPHARMACEUTICAL MARKET FORECAST (2017-2022)

10.1 EMEA Radiopharmaceutical Sales, Revenue and Growth Rate (2017-2022)
10.2 Radiopharmaceutical Market Forecast by Regions (2017-2022)
  10.2.1 Europe Radiopharmaceutical Market Forecast by Regions (2017-2022)
    10.2.1.1 Germany Radiopharmaceutical Sales Forecast 2017-2022
    10.2.1.2 France Radiopharmaceutical Sales Forecast 2017-2022
    10.2.1.3 UK Radiopharmaceutical Sales Forecast 2017-2022
    10.2.1.4 Russia Radiopharmaceutical Sales Forecast 2017-2022
    10.2.1.5 Italy Radiopharmaceutical Sales Forecast 2017-2022
    10.2.1.6 Turkey Radiopharmaceutical Sales Forecast 2017-2022
  10.2.2 Middle East Market Forecast by Regions (2017-2022)
    10.2.2.1 Saudi Arabia Radiopharmaceutical Sales Forecast 2017-2022
    10.2.2.2 Israel Radiopharmaceutical Sales Forecast 2017-2022
    10.2.2.3 UAE Radiopharmaceutical Sales Forecast 2017-2022
    10.2.2.4 Iran Radiopharmaceutical Sales Forecast 2017-2022
  10.2.3 Africa Market Forecast by Regions (2017-2022)
    10.2.3.1 South Africa Radiopharmaceutical Sales Forecast 2017-2022
    10.2.3.2 Nigeria Radiopharmaceutical Sales Forecast 2017-2022
    10.2.3.3 Egypt Radiopharmaceutical Sales Forecast 2017-2022
    10.2.3.4 Algeria Radiopharmaceutical Sales Forecast 2017-2022
10.3 Radiopharmaceutical Market Forecast by Type (2017-2022)
10.4 Radiopharmaceutical Market Forecast by Application (2017-2022)

11 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

11.1 Sales Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Future Trend
11.2 Distributors, Traders and Dealers

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Radiopharmaceutical Picture
Table Product Specifications of Radiopharmaceutical
Figure EMEA Sales Market Share of Radiopharmaceutical by Types in 2016
Table Radiopharmaceutical Types for Major Manufacturers
Figure Diagnostic Radioisotopes Picture
Figure Therapeutic Radioisotopes Picture
Table Radiopharmaceutical Sales Market Share by Applications in 2016
Figure Oncology Picture
Figure Cardiology Picture
Figure Other Picture
Figure Germany Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure France Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure UK Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Turkey Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure UAE Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Israel Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Iran Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Algeria Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Radiopharmaceutical Type and Applications
Table Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table Triad Isotopes Radiopharmaceutical Type and Applications
Table Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lantheus Basic Information, Manufacturing Base and Competitors
Table Lantheus Radiopharmaceutical Type and Applications
Table Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GE Healthcare Basic Information, Manufacturing Base and Competitors
Table GE Healthcare Radiopharmaceutical Type and Applications
Table GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table Mallinckrodt Radiopharmaceutical Type and Applications
Table Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Radiopharmaceutical Type and Applications
Table Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table Bracco Imaging Radiopharmaceutical Type and Applications
Table Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SIEMENS Basic Information, Manufacturing Base and Competitors
Table SIEMENS Radiopharmaceutical Type and Applications
Table SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Navidea Basic Information, Manufacturing Base and Competitors
Table Navidea Radiopharmaceutical Type and Applications
Table Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Nordion Basic Information, Manufacturing Base and Competitors
Table Nordion Radiopharmaceutical Type and Applications
Table Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table IBA Group Basic Information, Manufacturing Base and Competitors
Table IBA Group Radiopharmaceutical Type and Applications
Table IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table Jubilant Pharma Radiopharmaceutical Type and Applications
Table Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EMEA Radiopharmaceutical Sales by Manufacturer (2016-2017)
Figure EMEA Radiopharmaceutical Sales Market Share by Manufacturer in 2016
Figure EMEA Radiopharmaceutical Sales Market Share by Manufacturer in 2017
Table EMEA Radiopharmaceutical Revenue by Manufacturer (2016-2017)
Figure EMEA Radiopharmaceutical Revenue Market Share by Manufacturer in 2016
Figure EMEA Radiopharmaceutical Revenue Market Share by Manufacturer in 2017
Table EMEA Radiopharmaceutical Price by Manufacturer (2016-2017)
Figure EMEA Radiopharmaceutical Sales and Growth (2012-2017)
Figure EMEA Radiopharmaceutical Revenue and Growth (2012-2017)
Table EMEA Radiopharmaceutical Sales by Regions (2012-2017)
Table EMEA Radiopharmaceutical Sales Market Share by Regions (2012-2017)
Figure EMEA Radiopharmaceutical Sales Market Share by Regions in 2012
Figure EMEA Radiopharmaceutical Sales Market Share by Regions in 2016
Table EMEA Radiopharmaceutical Revenue by Regions (2012-2017)
Table EMEA Radiopharmaceutical Revenue Market Share by Regions (2012-2017)
Figure EMEA Radiopharmaceutical Revenue Market Share by Regions in 2012
Figure EMEA Radiopharmaceutical Revenue Market Share by Regions in 2016
Figure Europe Radiopharmaceutical Sales and Growth (2012-2017)
Figure Middle East Radiopharmaceutical Sales and Growth (2012-2017)
Figure Africa Radiopharmaceutical Sales and Growth (2012-2017)
Figure Europe Radiopharmaceutical Revenue and Growth (2012-2017)
Table Europe Radiopharmaceutical Sales by Countries (2012-2017)
Table Europe Radiopharmaceutical Sales Market Share by Countries (2012-2017)
Figure Europe Radiopharmaceutical Sales Market Share by Countries in 2012
Figure Europe Radiopharmaceutical Sales Market Share by Countries in 2016
Table Europe Radiopharmaceutical Revenue by Countries (2012-2017)
Table Europe Radiopharmaceutical Revenue Market Share by Countries (2012-2017)
Figure Europe Radiopharmaceutical Revenue Market Share by Countries in 2012
Figure Europe Radiopharmaceutical Revenue Market Share by Countries in 2016
Figure Germany Radiopharmaceutical Sales and Growth (2012-2017)
Figure France Radiopharmaceutical Sales and Growth (2012-2017)
Figure UK Radiopharmaceutical Sales and Growth (2012-2017)
Figure Russia Radiopharmaceutical Sales and Growth (2012-2017)
Figure Italy Radiopharmaceutical Sales and Growth (2012-2017)
Figure Turkey Radiopharmaceutical Sales and Growth (2012-2017)
Table Europe Radiopharmaceutical Sales by Manufacturer (2016-2017)
Figure Europe Radiopharmaceutical Sales Market Share by Manufacturer in 2016
Figure Europe Radiopharmaceutical Sales Market Share by Manufacturer in 2017
Table Europe Radiopharmaceutical Revenue by Manufacturer (2016-2017)
Figure Europe Radiopharmaceutical Revenue Market Share by Manufacturer in 2016
Figure Europe Radiopharmaceutical Revenue Market Share by Manufacturer in 2017
Table Europe Radiopharmaceutical Sales by Type (2012-2017)
Table Europe Radiopharmaceutical Sales Share by Type (2012-2017)
Table Europe Radiopharmaceutical Sales by Application (2012-2017)
Table Europe Radiopharmaceutical Sales Share by Application (2012-2017)
Figure Middle East Radiopharmaceutical Revenue and Growth (2012-2017)
Table Middle East Radiopharmaceutical Sales by Countries (2012-2017)
Table Middle East Radiopharmaceutical Sales Market Share by Countries (2012-2017)
Figure Middle East Radiopharmaceutical Sales Market Share by Countries in 2012
Figure Middle East Radiopharmaceutical Sales Market Share by Countries in 2016
Table Middle East Radiopharmaceutical Revenue by Countries (2012-2017)
Table Middle East Radiopharmaceutical Revenue Market Share by Countries (2012-2017)
Figure Middle East Radiopharmaceutical Revenue Market Share by Countries in 2012
Figure Middle East Radiopharmaceutical Revenue Market Share by Countries in 2016
Figure Saudi Arabia Radiopharmaceutical Sales and Growth (2012-2017)
Figure Israel Radiopharmaceutical Sales and Growth (2012-2017)
Figure UAE Radiopharmaceutical Sales and Growth (2012-2017)
Figure Iran Radiopharmaceutical Sales and Growth (2012-2017)
Table Middle East Radiopharmaceutical Sales by Manufacturer (2016-2017)
Figure Middle East Radiopharmaceutical Sales Market Share by Manufacturer in 2016
Figure Middle East Radiopharmaceutical Sales Market Share by Manufacturer in 2017
Table Middle East Radiopharmaceutical Revenue by Manufacturer (2016-2017)
Figure Middle East Radiopharmaceutical Revenue Market Share by Manufacturer in 2016
Figure Middle East Radiopharmaceutical Revenue Market Share by Manufacturer in 2017
Table Middle East Radiopharmaceutical Sales by Type (2012-2017)
Table Middle East Radiopharmaceutical Sales Share by Type (2012-2017)
Table Middle East Radiopharmaceutical Sales by Application (2012-2017)
Table Middle East Radiopharmaceutical Sales Share by Application (2012-2017)
Figure Africa Radiopharmaceutical Revenue and Growth (2012-2017)
Table Africa Radiopharmaceutical Sales by Countries (2012-2017)
Table Africa Radiopharmaceutical Sales Market Share by Countries (2012-2017)
Figure Africa Radiopharmaceutical Sales Market Share by Countries in 2012
Figure Africa Radiopharmaceutical Sales Market Share by Countries in 2016
Table Africa Radiopharmaceutical Revenue by Countries (2012-2017)
Table Africa Radiopharmaceutical Revenue Market Share by Countries (2012-2017)
Figure Africa Radiopharmaceutical Revenue Market Share by Countries in 2012
Figure Africa Radiopharmaceutical Revenue Market Share by Countries in 2016
Figure South Africa Radiopharmaceutical Sales and Growth (2012-2017)
Figure Nigeria Radiopharmaceutical Sales and Growth (2012-2017)
Figure Egypt Radiopharmaceutical Sales and Growth (2012-2017)
Figure Algeria Radiopharmaceutical Sales and Growth (2012-2017)
Table Middle East Radiopharmaceutical Sales by Manufacturer (2016-2017)
Figure Middle East Radiopharmaceutical Sales Market Share by Manufacturer in 2016
Figure Middle East Radiopharmaceutical Sales Market Share by Manufacturer in 2017
Table Middle East Radiopharmaceutical Revenue by Manufacturer (2016-2017)
Figure Middle East Radiopharmaceutical Revenue Market Share by Manufacturer in 2016
Figure Middle East Radiopharmaceutical Revenue Market Share by Manufacturer in 2017
Table Middle East Radiopharmaceutical Sales by Type (2012-2017)
Table Middle East Radiopharmaceutical Sales Share by Type (2012-2017)
Table Middle East Radiopharmaceutical Sales by Application (2012-2017)
Table Middle East Radiopharmaceutical Sales Share by Application (2012-2017)
Table EMEA Radiopharmaceutical Sales by Type (2012-2017)
Table EMEA Radiopharmaceutical Sales Share by Type (2012-2017)
Table EMEA Radiopharmaceutical Revenue by Type (2012-2017)
Table EMEA Radiopharmaceutical Revenue Share by Type (2012-2017)
Figure EMEA Diagnostic Radioisotopes Sales Growth (2012-2017)
Figure EMEA Diagnostic Radioisotopes Price (2012-2017)
Figure EMEA Therapeutic Radioisotopes Sales Growth (2012-2017)
Figure EMEA Therapeutic Radioisotopes Price (2012-2017)
Table EMEA Radiopharmaceutical Sales by Application (2012-2017)
Table EMEA Radiopharmaceutical Sales Share by Application (2012-2017)
Figure EMEA Oncology Sales Growth (2012-2017)
Figure EMEA Cardiology Sales Growth (2012-2017)
Figure EMEA Other Sales Growth (2012-2017)
Figure EMEA Radiopharmaceutical Sales, Revenue and Growth Rate (2017-2022)
Table EMEA Radiopharmaceutical Sales Forecast by Regions (2017-2022)
Table EMEA Radiopharmaceutical Market Share Forecast by Regions (2017-2022)
Table Europe Radiopharmaceutical Sales Forecast by Regions (2017-2022)
Figure Germany Radiopharmaceutical Sales Forecast 2017-2022
Figure France Radiopharmaceutical Sales Forecast 2017-2022
Figure UK Radiopharmaceutical Sales Forecast 2017-2022
Figure Russia Radiopharmaceutical Sales Forecast 2017-2022
Figure Italy Radiopharmaceutical Sales Forecast 2017-2022
Figure Turkey Radiopharmaceutical Sales Forecast 2017-2022
Table Middle East Sales Forecast by Regions (2017-2022)
Figure Saudi Arabia Radiopharmaceutical Sales Forecast 2017-2022
Figure Israel Radiopharmaceutical Sales Forecast 2017-2022
Figure UAE Radiopharmaceutical Sales Forecast 2017-2022
Figure Iran Radiopharmaceutical Sales Forecast 2017-2022
Table Africa Sales Forecast by Regions (2017-2022)
Figure South Africa Radiopharmaceutical Sales Forecast 2017-2022
Figure Nigeria Radiopharmaceutical Sales Forecast 2017-2022
Figure Egypt Radiopharmaceutical Sales Forecast 2017-2022
Figure Algeria Radiopharmaceutical Sales Forecast 2017-2022
Table EMEA Radiopharmaceutical Sales Forecast by Type (2017-2022)
Table EMEA Radiopharmaceutical Market Share Forecast by Type (2017-2022)
Table EMEA Radiopharmaceutical Sales Forecast by Application (2017-2022)
Table EMEA Radiopharmaceutical Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List